Oral contraceptives and hormonal replacement therapy cause an imbalance in coagulation and fibrinolysis which may explain the increased risk of venous thromboembolism

Cardiovasc Res. 1999 Jan;41(1):21-4. doi: 10.1016/s0008-6363(98)00210-7.
No abstract available

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Blood Coagulation / drug effects*
  • Contraceptives, Oral, Hormonal / adverse effects*
  • Estrogen Replacement Therapy / adverse effects*
  • Female
  • Fibrinolysis / drug effects*
  • Humans
  • Risk Factors
  • Thromboembolism / chemically induced*

Substances

  • Contraceptives, Oral, Hormonal